Tumor-based rhythms of anticancer efficacy in experimental models
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Chronobiology International
- Vol. 19 (1) , 21-41
- https://doi.org/10.1081/cbi-120002589
Abstract
Experimental tumor models constitute a prerequisite toward chronotherapy testing in cancer patients. Studies in experimental models are required to understand the relation between tumor rhythms and...Keywords
This publication has 28 references indexed in Scilit:
- Circadian chronotherapy for human cancersThe Lancet Oncology, 2001
- Circadian organization of thymidylate synthase activity in normal tissues: A possible basis for 5-fluorouracil chronotherapeutic advantageInternational Journal of Cancer, 2000
- Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flowInternational Journal of Cancer, 1996
- Rhythm alteration in patients with metastatic breast cancer and poor prognostic factorsZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Circadian and Ultradian Cytokinetic Rhythms of Spontaneous Human CanceraAnnals of the New York Academy of Sciences, 1991
- Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen Receptor Positive Breast CancerScience, 1982
- Liver cell control after discontinuation of DENA feeding in hepatocarcinogenesisPublished by Elsevier ,1981
- Evidence of a G1regulation of circadian proliferation in mouse methylcholanthrene-induced sarcomasPublished by Elsevier ,1979
- Circadian rhythms in DNA synthesis and mitosis in normal mice and in mice bearing the Lewis lung carcinomaPublished by Elsevier ,1979
- Toward a chronotherapy of neoplasia: Tolerance of treatment depends upon host rhythmsCellular and Molecular Life Sciences, 1973